ClinicalTrials.govpublic full text
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
pancreatic cancer, pancreatic carcinoma, pancreatic cancer non-resectable, pancreatic cancer stage iv, claudin 18.2, car-t, mesothelin, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 848789
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.